Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis
Clinical trial NCT01395316 · COMPLETED
Trial details
- NCT number
- NCT01395316
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.